AYTU BioPharma
AYTU
AYTU
21 hedge funds and large institutions have $1.18M invested in AYTU BioPharma in 2023 Q1 according to their latest regulatory filings, with 2 funds opening new positions, 7 increasing their positions, 9 reducing their positions, and 17 closing their positions.
New
Increased
Maintained
Reduced
Closed
more ownership
Funds ownership: →
less repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
less capital invested
Capital invested by funds: $ → $
less funds holding
Funds holding: →
88% less first-time investments, than exits
New positions opened: 2 | Existing positions closed: 17
Holders
21
Holding in Top 10
–
Calls
–
Puts
–
Top Buyers
| 1 | +$608K | |
| 2 | +$106K | |
| 3 | +$11.7K | |
| 4 |
UBS Group
Zurich,
Switzerland
|
+$11.2K |
| 5 |
Acadian Asset Management
Boston,
Massachusetts
|
+$5.86K |
Top Sellers
| 1 | -$225K | |
| 2 | -$184K | |
| 3 | -$128K | |
| 4 |
ACM
Allred Capital Management
Dallas,
Texas
|
-$23.6K |
| 5 |
State Street
Boston,
Massachusetts
|
-$18.5K |